Global Health NewsNon- Communicable Diseases (NCDs)Public HealthPublic Health NewsPublic Health Update

Accelerate efforts to eliminate cervical cancer: WHO

by Public Health Update
written by Public Health Update

Accelerate efforts to eliminate cervical cancer: WHO

New Delhi, 6 September 2019

World Health Organization urged countries in its South-East Asia Region to accelerate efforts to eliminate cervical cancer by 2030.

“Countries need to expand vaccination, screening, detection and treatment services for everyone, everywhere to address the growing problem of cervical cancer,” said Dr Poonam Khetrapal Singh, Regional Director WHO South-East Asia, at the Seventy Second Session of WHO Regional Committee here in Delhi.

Cervical cancer is a significant public health problem in the Region. In 2018, an estimated 158 000 new cases and 95 766 deaths were reported due to cervical cancer, which is the third most common type of cancer.

Addressing cancer risk factors and reducing its prevalence has been a regional flagship priority since 2014. All countries in the Region are taking measures for screening and treatment of pre-cancers. Four countries in the Region – Bhutan, Maldives, Sri Lanka and Thailand – have introduced HPV vaccine nationally.

“We need to scale up both our capacities and quality for screening, treatment services and palliative care,” the Regional Director said.

Vaccination against human papillomavirus, screening and treatment of pre-cancer, early detection, and prompt treatment of early invasive cancers and palliative care are proven effective strategies to address cervical cancer.

Member countries are working towards interim global targets – of achieving 90% girls fully vaccinated with the human papilloma virus (HPV) vaccine by 15 years of age; 70% women screened with a high-precision test at 35 and 45 years of age, and 90% women identified with the cervical disease receive treatment and care by 2030.

The Regional Director said there is need to strengthen national cervical cancer control plans, including appropriate strategies and guidelines for immunization, screening, treatment and care, including palliative care.

“It is necessary to include these services in the essential services packages towards universal health coverage to meet the targets,” Dr Khetrapal Singh said.

WHO is prioritizing cervical cancer elimination as worldwide cervical cancer remains one of the gravest threats to women’s lives.

SEAR/PR/1720

HPV Vaccination program inaugurated from Pokhara, Kaski (Photos)

Prevention and Control of Cervical Cancer (New WHO guide)

The National Immunization Programme (National Immunization Schedule), Nepal

0 comments
0 FacebookTwitterPinterestLinkedinTumblrVKOdnoklassnikiRedditStumbleuponWhatsappTelegramLINEPocketSkypeViberEmail
Global Health NewsPublic HealthPublic Health NewsPublic Health UpdateVaccine Preventable Diseases

WHO South-East Asia Region sets 2023 target to eliminate measles, rubella

by Public Health Update
written by Public Health Update

WHO South-East Asia Region sets 2023 target to eliminate measles, rubella

New Delhi, 5 September 2019: Member Countries of WHO South-East Asia Region resolved to eliminate measles and rubella by 2023, to prevent deaths and disabilities caused by these highly infectious childhood killers diseases.

“The new target to eliminate both the diseases will leverage the existing momentum and strong political commitment which is being demonstrated through unprecedented efforts, progress and successes in recent years,” said Dr Poonam Khetrapal Singh, Regional Director WHO South-East Asia, as a resolution to eliminate the two diseases was adopted at the Seventy Second Session of WHO Regional Committee for South-East Asia here in New Delhi.

Measles elimination and rubella control has been a regional flagship priority since 2014. Five countries have eliminated measles – Bhutan, DPR Korea, Maldives, Sri Lanka and Timor-Leste. Six countries have controlled rubella – Bangladesh, Bhutan, Maldives, Nepal, Sri Lanka and Timor-Leste.

To achieve the new targets, the Member countries resolved to strengthen immunization systems for increasing and sustaining high level of population immunity against measles and rubella at both national and sub-national levels.

The resolution calls for ensuring a highly sensitive laboratory supported case-based surveillance system – better evidence for appropriate planning and response. It also emphasizes on preparedness for outbreak response activities for measles and rubella.

All countries pledged to mobilize political, societal and financial support to ensure interruption of transmission of indigenous measles and rubella virus by 2023.

The Member countries adopted a “Strategic Plan for Measles and Rubella Elimination 2020-2024” that lays down the road map and focus areas to achieve the elimination targets in the Region.

“Eliminating measles will prevent 500,000 deaths a year in the Region, while eliminating rubella/ CRS would avert about 55,000 cases of rubella and promote health and well-being of pregnant woman and infants,” the Regional Director said.

The drive against measles and rubella/CRS gathered crucial momentum after 2014, when ‘Measles Elimination and Rubella/CRS Control by 2020’ was declared one of the eight Flagship Priority programmes for the Region and a Regional Strategic Plan was implemented across the Member States.

There has been a 23% decline in mortality due to measles in the 2014-17 period. Nearly 366 million children have been reached through mass vaccination campaigns with measles-rubella (MR) containing vaccines in the Region since January 2017.

Children in all 11 Member countries have access to 2 doses of measles containing vaccine (MCV) and ten countries have access to rubella-containing vaccine.

The decision to revise the targets of measles and rubella elimination was preceded by several consultations, including during the WHO South-East Asia Regional Immunization Technical Advisory Group meeting in July 2019. The WHO Regional Office for South-East Asia also conducted high-level consultations, in March 2019, with Member States on the feasibility of adopting the new target.

Measles is particularly dangerous for the poor, as it attacks malnourished children and those with reduced immunity. Measles can cause serious complications, including blindness, encephalitis, severe diarrhoea, ear infection and pneumonia while rubella/ congenital rubella syndrome (CRS) causes irreversible birth defects.

SEAR/PR/1719

Sri Lanka ?? eliminates measles

Substantial decline in global measles deaths, but disease still kills 90 000 per year

Bhutan, Maldives eliminate measles

National Immunization Schedule, Nepal (Revised)

World Immunization Week- Protected Together: #VaccinesWork!

0 comments
0 FacebookTwitterPinterestLinkedinTumblrVKOdnoklassnikiRedditStumbleuponWhatsappTelegramLINEPocketSkypeViberEmail
Communicable DiseasesGlobal Health NewsInternational Plan, Policy & GuidelinesPublic HealthPublic Health NewsPublic Health UpdateResearch & Publication

South-East Asia Regional Action Plan on the Programmatic Management of Latent TB Infection launched

by Public Health Update
written by Public Health Update

South-East Asia Regional Action Plan on the Programmatic Management of Latent Tuberculosis Infection launched

Health Ministers and experts from Member States of WHO South-East Asia Region began a week-long meeting in New Delhi this week to deliberate on priority public health issues and build on the recent momentum for elimination of communicable diseases. On 4 September, the Seventy-second meeting of the South-East Asia Regional Committee unanimously adopted the South-East Asia Regional Action Plan on the Programmatic Management of Latent Tuberculosis Infection. This plan developed through broad consultative process with country stakeholders, civil society and community partners and technical experts, aligns completely with the latest WHO guidelines on programmatic management of latent TB infection and aims to assist Member States in updating national policies, and prepare the health and community systems to launch adequate national response for provision of TB preventive treatment to all target populations.

Screen Shot 2019 09 05 at 18.42.15

Download: South-East Asia Regional Action Plan on Programmatic Management of Latent Tuberculosis Infection

Dissemination of Findings and Recommendations of Joint External Monitoring Mission(JEMM) of Nepal National Tuberculosis Program

National Tuberculosis Programme Annual Report 2018

World Tuberculosis Day Observed with theme “It’s Time”

Building a tuberculosis-free world: The Lancet Commission on tuberculosis

0 comments
0 FacebookTwitterPinterestLinkedinTumblrVKOdnoklassnikiRedditStumbleuponWhatsappTelegramLINEPocketSkypeViberEmail
Global Health NewsHumanitarian Health & Emergency ResponsePublic HealthPublic Health NewsPublic Health Update

Member countries of WHO South-East Asia Region pledge to strengthen Emergency Preparedness

by Public Health Update
written by Public Health Update

Member countries of WHO South-East Asia Region pledge to strengthen Emergency Preparedness

New Delhi, 4 September 2019: Prone to multiple hazards, Member countries of WHO South-East Asia Region have pledged to strengthen emergency preparedness capacities by scaling up risk assessment, increasing investments, and enhancing implementation of multi-sectoral plans.

As Member countries adopted the ‘Delhi Declaration – Emergency Preparedness in the South-East Asia Region’ at a Ministerial Round Table in New Delhi, the Regional Director, Dr Poonam Khetrapal Singh, underscored the importance of preparedness saying, “stronger the capacities in our own countries, stronger will be the Region and stronger will be the world.”

The WHO Director General, Dr Tedros Adhanom Ghebreyesus, who connected from Geneva to the Seventy-Second Session of WHO South-East Asia Regional Committee, said, “preparedness will save lives, and save money. The Delhi declaration on emergency preparedness is a vital step forward towards making the Region safer for all its people.”

The Delhi declaration calls for four key initiatives – identify risks by mapping and assessing vulnerabilities for evidence-based planning, implement measures for disaster risk reduction; prepare and operationalize readiness.

Invest in people and systems for risk management, by strengthening IHR core capacities, building resilient health systems and infrastructure, surge capacity through national emergency medical teams and rapid response teams. The commitment to invest more, also emphasizes on continued and greater support to South-East Asia Regional Health Emergency Fund (SEARHEF)’s preparedness stream.

The declaration also calls for implementing, monitoring, testing and adequately funding national action plans on disaster risk management, emergency preparedness and response.

Lastly, it emphasizes on interlinking sectors and networks – such as the ‘One Health’ approach to bridge the gap between diverse sectors including human, animal, environment – for prevention and control of emerging and re-emerging diseases.

Participating in the roundtable, Ministers of Health and heads of delegations of the 11 Member countries, that account for one-fourth of the global population, shared experiences from the numerous health emergencies that have hit the Region in the last over a decade. “We have a lot to share and learn from each other,” the Regional Director said.

The turning point was the Indian Ocean tsunami, that killed over 200,000 people, and caused massive destruction in six countries of the Region. The Region then set benchmarks for disaster preparedness and response and created the regional health emergency fund SEARHEF that has funded 39 emergencies in 9 countries, disbursing 6.07 million USD.

Despite improved capacities and responses to health emergencies, WHO South-East Asia continues to be one of the most vulnerable Regions at risk of emerging and re-emerging diseases, diseases associated with climate change and rapid and unplanned urbanization, and natural disasters such as floods, cyclones, earthquakes and volcano eruptions.

Since 2014, the start of the first term of the Regional Director, scaling up emergency risk capacities has been a Regional flagship priority. In her second term that began in 2019 February, the Regional Director has asked for sustain efforts to strengthen emergency preparedness and response; accelerate investments to address critical gaps at national and sub-national levels; and innovate to continuously improve preparedness and response system.

The Regional flagship is aligned to WHO’s global triple billion goal – one billion more people better protected from health emergencies, one billion more people enjoying better health and wellbeing and one billion more people benefitting from universal health coverage.

SEAR/PR/1718

Global health leaders adopt Delhi Declaration on digital health

Delhi TB Summit: WHO South-East Asia countries commit to intensified efforts, concrete progress to End TB

Six WHO South-East Asia countries felicitated for public health achievements

Provincial Health Emergency Operations Centre Handover, Pokhara

Health Ministers of WHO South-East Asia Region to discuss key challenges next week

0 comments
0 FacebookTwitterPinterestLinkedinTumblrVKOdnoklassnikiRedditStumbleuponWhatsappTelegramLINEPocketSkypeViberEmail
National Plan, Policy & GuidelinesNeglected Tropical Diseases (NTDs)Public HealthResearch & Publication

National Malaria Treatment Protocol 2019, Nepal – EDCD

by Public Health Update
written by Public Health Update

National Malaria Treatment Protocol 2019, Nepal – EDCD

Malaria case management, consisting of early diagnosis and prompt effective treatment, remains a vital component of malaria control and elimination strategies. This National Malaria Treatment Protocol 2019 contains updated recommendations based on national adaptation of global WHO recommendations to provide guidance to health workers to ensure that optimal care is provided for malaria patients and contribute to achieving the goal of malaria elimination in Nepal by 2025.

Diagnosis of malaria

  • Always obtain a travel history.
  • All cases of suspected malaria should have a parasitological test (microscopy or RDT) to confirm the diagnosis. RDTs should be used when microscopy is not feasible.
  • Use of both microscopy and RDTs should be supported by a quality assurance programme.

Treating uncomplicated P. vivax, P. ovale, P. malariae or P. knowlesi malaria

  • Treat with chloroquine (3 days) and primaquine (14 days) for P. vivax and P. ovale.
  • Treat with chloroquine (3 days) for P. malariae or P. knowlesi.

Blood stage infection

  • 1st line – chloroquine
  • 2nd line (chloroquine-resistance infection) – dihydroartemisinin + piperaquine

Preventing relapse in P. vivax or P. ovale malaria

  • 14-day course of primaquine – (except pregnant women, infants aged < 6 months, and women breastfeeding infants aged < 6 months).
  • G6PD testing is encouraged prior to 14 days PQ therapy but in case testing is not available closely supervised 14 days PQ therapy will be given.
  • Counselling should be done to patient and followed up on days 3-7-14 days to monitor for adverse effects and compliance with primaquine.

Pregnant or breastfeeding women

  • Treat with chloroquine for 3 days. Provide weekly chemoprophylaxis with chloroquine until delivery and breastfeeding are completed, then, treat with primaquine for 14 days to prevent future relapse.

Treating uncomplicated P. falciparum malaria

  • Treat with AL (3 Days) and Primaquine on Day 1
  • Treatment of uncomplicated P. falciparum malaria
    1st line – artemether + lumefantrine (AL)
    2nd line – dihydroartemisinin + piperaquine (DHA/PPQ)

Reducing the transmissibility of treated P. falciparum infections.

  • Primaquine single dose of 0.25 mg/kg bw – (except in pregnant women, infants aged < 6 months and women breastfeeding infants aged < 6 months). Testing for glucose-6-phosphate dehydrogenase (G6PD) is not required.

Pregnant or breastfeeding women

  • Treat pregnant women all trimesters and lactating mothers with the first line ACT (AL) as in non-pregnant women. Provide primaquine single dose of 0.25 mg/kg bw after delivery and breastfeeding completed.

Treating severe malaria

  • Intravenous or intramuscular artesunate for at least 24 hr. Once a patient has received at least 24 hr of parenteral therapy and can tolerate oral therapy, complete treatment with full course artemether + lumefantrine with single dose primaquine for falciparum and primaquine for radical cure of vivax (14 days).
  • Children weighing < 20 kg should receive a higher dose of artesunate (3 mg/kg bw per dose) than larger children and adults (2.4 mg/kg bw per dose).

Pre-referral treatment

  • A single intramuscular dose of artesunate and refer to an appropriate facility for further care.

Chemoprophylaxis

  • Malaria prophylaxis is not necessary for in-country travel within Nepal.
  • Prophylactic medication for malaria is recommended for Nepalese traveling to countries with areas of malaria transmission.
  • The medicine of choice depends on the parasite species and resistance profile in the destination country.

DOWNLOAD PDF FILE

DOWNLOAD PDF FILE

Screen Shot 2019 09 04 at 12.13.36

National Malaria Surveillance Guidelines 2019, Nepal

Malaria Micro Stratification Report 2018

Epidemiological Trend of Malaria in Nepal (2012/13-2017/18)

Defeating malaria demands high-impact, country-led and owned approaches

Algeria and Argentina certified malaria-free by WHO

Malaria vaccine pilot launched in Malawi

The World Malaria Report 2018

0 comments
0 FacebookTwitterPinterestLinkedinTumblrVKOdnoklassnikiRedditStumbleuponWhatsappTelegramLINEPocketSkypeViberEmail
Public HealthUniversal Health Coverage

Sign the petition – Add your voice to the call for #HealthForAll

by Public Health Update
written by Public Health Update

Sign the petition – Add your voice to the call for #HealthForAll

Universal health coverage means that all people have access to health services they need, when and where they need them, without financial hardship.

UNIVERSAL HEALTH COVERAGE

We believe everyone should have access to the health services they need, when they need it, without facing financial hardship. Health for all people in the world is possible. Help lead the way to making it a reality.

Universal health coverage is a political choice. I call on all leaders to make that choice! Everyone can express their support for #HealthForAll by signing this petition-  Dr. Tedros Adhanom Ghebreyesus

Currently, for at least half of the people in the world this is not possible. About 100 million people are pushed into extreme poverty each year because of out-of-pocket spending on health. This must change.

To make health for all a reality, we need commitment at all levels of society to ensure high-quality services to all people as close to home as possible.

 

Sign the petition – Add your voice to the call for #HealthForAll (Click Here)

World Bank and WHO: Half the world lacks access to essential health services, 100 million still pushed into extreme poverty because of health expenses

Quality primary care key to advancing universal health coverage: WHO

e-Learning Course on Health Financing Policy for universal health coverage

Universal Health Coverage (UHC)

0 comments
0 FacebookTwitterPinterestLinkedinTumblrVKOdnoklassnikiRedditStumbleuponWhatsappTelegramLINEPocketSkypeViberEmail
Global Health NewsMaternal, Newborn and Child HealthPublic HealthPublic Health NewsPublic Health UpdateSuccess Stories

Six WHO South-East Asia countries felicitated for public health achievements

by Public Health Update
written by Public Health Update

Six WHO South-East Asia countries felicitated for public health achievements

Congratulations Nepal??️, Bangladesh??️, Bhutan??️, Maldives??️, Sri Lanka and Thailand??

 

New Delhi, 3 September 2019: Ministers of Health of six Member countries of WHO South-East Asia Region were today felicitated for public health achievements in recent months such as measles elimination, hepatitis B control, and elimination of mother-to-child transmission of HIV and Syphilis.

Sri Lanka was recognized for eliminating measles; Bangladesh, Bhutan, Nepal and Thailand for becoming the first four countries from the Region to control Hepatitis B; and Maldives for eliminating mother-to-child transmission of HIV and Syphilis.

69476828 1630987743698526 8754563033507823616 n

Presenting citations to the Ministers for their public health achievements at a side event during the Seventy Second Session of WHO Regional Committee of South-East Asia in New Delhi, the Regional Director, Dr Poonam Khetrapal Singh, and said, “disease eliminations have always been high on our agenda. When I talk about sustain, accelerate and innovate, ‘accelerate’ is to step up efforts to eliminate diseases like the neglected tropical diseases.”

The Minister of Health, Nutrition and Indigenous Medicine, Sri Lanka, Dr Rajitha Senaratne, was presented the citation for measles elimination. Sri Lanka is the fifth country in the Region to eliminate measles, a flagship priority program of WHO in South-East Asia since 2014.

The citations for Hepatitis B control were presented to Nepal’s Deputy Prime Minister and Health Minister, Mr Upendra Yadav, Bhutan’s Minister of Health, Ms Dechen Wangmo; Thailand’s Deputy Minister of Public Health, Mr Sathit Pitutecha, and Additional Secretary, Health Services Division, Bangladesh, Mr Md Saidur Rahman. Controlling hepatitis B by reducing disease prevalence to less than one per cent among five-year-olds, significantly reduces chronic infections and cases of liver cancer and cirrhosis in adulthood.

Citations for Hepatitis B control presented to Nepal’s Deputy Prime Minister and Health Minister Mr. Upendra Yadav WHO

The Minister of Health of Maldives, Mr Abdulla Ameen, was presented a citation for eliminating mother-to-child transmission of HIV and Syphilis. Maldives is only the second country in the Region to have achieved this feat after Thailand.

This is the fourth consecutive year that the public health achievements awards were presented to Member countries on the sidelines of the Regional Committee Session. With focused and concerted efforts, Member countries are making substantial progress around the priority health issues.

WHO SEARO PRESS RELEASE SEAR/PR/1717

Health Ministers of WHO South-East Asia Region to discuss key challenges next week

Bangladesh, Bhutan, Nepal and Thailand achieve Hepatitis B control: WHO

Bhutan, Maldives eliminate measles

Thailand becomes trans fat free country ??

Algeria and Argentina certified malaria-free by WHO

Nepal: first country in South-East Asia validated for eliminating trachoma

Maldives ?? eliminates mother-to-child transmission of HIV, Syphilis

Sri Lanka ?? eliminates measles

Bhutan, Maldives eliminate measles

Kenya now eliminates maternal and neonatal tetanus

Malaysia eliminates mother-to-child transmission of HIV and syphilis

5 Years of Polio-free WHO South-East Asia Region

Thailand becomes trans fat free country ??

Thailand becomes first in Asia to introduce tobacco plain packaging

Nepal: first country in South-East Asia validated for eliminating trachoma

Bye – Bye ??? Trachoma ?‍??‍? from Nepal ??

Algeria and Argentina certified malaria-free by WHO

0 comments
0 FacebookTwitterPinterestLinkedinTumblrVKOdnoklassnikiRedditStumbleuponWhatsappTelegramLINEPocketSkypeViberEmail
Master of Science in Public Health (MSc.PH program), Kathmandu University
CoursesMaster's DegreeSchool of Public HealthSyllabusUniversities

Master of Science in Public Health (MSc.PH program), Kathmandu University

by Public Health Update
written by Public Health Update

Goal of the Program 

The MSc.PH program will produce competent public health graduates with advanced knowledge and practical skills to design and implement strategic public health solutions at national and global levels, conduct public health research, and train people in their respective fields of expertise.

This course is based on wide-range of pedagogical approaches including problem based learning, didactic lectures, journal clubs, online learning, seminars, workshops, etc. The students will benefit from the existing rural community-based health programs of Dhulikhel Hospital Kathmandu University Hospital; on-going research activities; and extensive national and international collaborative partnerships.

Objectives of the Program

MSc.PH in Epidemiology

Upon satisfactory completion of the MSc.PH in Epidemiology, graduates will be able to:

  • Use existing data to provide background to determine priorities and formulate public health investigations,
  • Create and/or use existing measurement instruments in collection of data to determine public health status and priorities and to evaluate interventions,
  • Create aims and objectives to address gaps in public health knowledge and programs,
  • Select appropriate study designs for interventions and investigations, considering their advantages and limitations,
  • Identify risk or preventive factors that may contribute to outcomes and incorporate them into preventive strategy,
  • Use software applications to collect, manage and analyse data to reveal associations and predict public health problems or solutions,
  • Interpret results of an epidemiologic study, including the relation to findings from other epidemiologic studies, the potential biological and/or social mechanisms, the limitations of the study, and the public health implications,
  • Critically review the scientific literature, synthesize the findings across studies, and make appropriate public health recommendations based on current knowledge,
  • Write a clear description of the rationale, methods, results and interpretation of an epidemiologic investigation,
  • Apply epidemiologic skills in public health settings, specifically in the formulation or application of public health programs or policies. 

MSc.PH in Global health

Upon satisfactory completion of the MSc. PH in Global Health graduates will be able to:

  • Perform evidence based health promotion and disease prevention projects, management, administration, implementation through team work and participation;
  • Analyse the most common causes of morbidity and mortality globally, both communicable and non-communicable, among new-borns, children, adolescents, men and women and apply this knowledge in design, implementation or evaluation of health services or programs;
  • Utilize the data from major components of health information systems (e.g. surveillance, national registries, surveys and administrative data) in planning, implementing and monitoring disease status and health programs;
  • Use quantitative and/or qualitative skills to assess effectiveness of health interventions in national and global setting;
  • Supervise health personnel to assist local development organizations that are concerned with global health;
  • Analyse important global health problems, inequity, and contribution to address the challenges including capacity building of research and education;
  • Incorporate rigorous epidemiologic study designs in program evaluation and implementation science in resource-poor settings;
  • Analyse how historical, political, and economic factors are shaping, maintaining and reforming health and health care systems; and
  • Apply scientific methods to plan, scale up and/or evaluate intervention and to improve determinants of health and health systems. 

Total Seat

  • 10

Course Duration

  • The two and half years program will be divided into five semesters including fifth semester will be compulsory internship.

Course Structure

Subjects in M.Sc. Public Health (Epidemiology) 

[* electives] 

First Semester

  1. Basic Concept in Public Health I
  2. Basic Concept in Public Health II
  3. Epidemiology I
  4. Biostatistics I
  5. Epidemiology II
  6. Biostatistics II
  7. Health Education and Health Promotion
  8. Recent Advances in Public Health
  9. Data Analysis and Statistical Software Usages

Second Semester

  1. Introduction to Research Methodology
  2. Proposal Writing and Scientific Communication
  3. Social, Behaviour, Population Science and Ethics in Health
  4. Health System and Public Health Planning (National and International)
  5. Qualitative Research Method
  6. Environmental and Occupational Health
  7. Community-orientated Health Practice
  8. Communicable Diseases*
  9. Non-communicable Diseases*
  10. Maternal, Child and Geriatric Health*
  11. Gender and Equity Issues in public health*
  12. Monitoring and Evaluation in Public health*
  13. Mental Health Issues in Public health*
  14. Literature Search and Management

Third Semester

  1. Advanced Epidemiology
  2. Advanced Biostatistics
  3. Systematic Review and Meta Analyses
  4. Epidemiology Seminars
  5. Independent Study
  6. Practicum

Fourth Semester

  1. Thesis

Fifth Semester

  1. Internship (6 months)

Subjects in M.Sc. Public Health (Global Health)

[* electives] 

First Semester

  1. Basic Concept in Public Health I
  2. Basic Concept in Public Health II
  3. Epidemiology I
  4. Biostatistics I
  5. Epidemiology II
  6. Biostatistics II
  7. Health Education and Health Promotion
  8. Recent Advances in Public Health
  9. Data Analysis and Statistical Software Usages

Second Semester

  1. Introduction to Research Methodology
  2. Proposal Writing and Scientific Communication
  3. Social, Behaviour, Population Science and Ethics in Health
  4. Health System and Public Health Planning (National and International)
  5. Qualitative Research Method
  6. Environmental and Occupational Health
  7. Community-orientated Health Practice
  8. Communicable Diseases*
  9. Non-communicable Diseases*
  10. Maternal, Child and Geriatric Health*
  11. Gender and Equity issues in Public Health*
  12. Monitoring and Evaluation in Public Health*
  13. Mental Health Issues in Public Health*
  14. Literature Search and Management

Third Semester

  1. Introduction to Global Health
  2. Implementation Science in Global Health
  3. Leadership and Health Management
  4. Health Policy
  5. Health Financing and Economic Evaluation
  6. Global Health Seminar
  7. Independent Study
  8. Project Management Practicum

Fourth Semester

Thesis

Fifth Semester

Internship (6 months)

Eligibility 

  • The eligible applicants will be any individual who has completed a minimum of three years’ Bachelor degree in public health or nursing or physiotherapy or laboratory science or optometry or imaging technology or pharmacy or human biology or MBBS/BDS or equivalent health sciences degree with minimum of 50% score.
  • Three years’ Bachelor Degree holders must have at least three years’ of work experience; and four years’ Bachelor Degree holders must have at least one year of work experience.
  • The work experience must be in health-related area.
  • Registered in respective professional council.

RELATED READING

·     

Important Documents for your entrance preparation

⚡ Looking for expert analysis, policy briefs, and high-level reviews on Nepal's health sector?

We are now offering premium subscription services to deliver timely, evidence-backed policy briefs, comprehensive technical reviews, and strategic analysis straight to your inbox. Tap into specialized consultant expertise and stay ahead on Nepal's emerging health strategies.

👉 [Contact Us]

Do you have a website? Looking for the best hosting provider? Here’s a discount code.

Latest Public Health Jobs

Latest Posts

Thanks for visiting us.
Disclaimer: The resources, documents, guidelines, and information on this blog have been collected from various sources and are intended for informational purposes only. Information published on or through this website and affiliated social media channels does not represent the intention, plan, or strategies of an organization that the initiator is associated with in a professional or personal capacity, unless explicitly indicated.
If you have any complaints, information, or suggestions about the content published on Public Health Update, please feel free to contact us at blog.publichealthupdate@gmail.com.
#StayUpdated

0 comments
0 FacebookTwitterPinterestLinkedinTumblrVKOdnoklassnikiRedditStumbleuponWhatsappTelegramLINEPocketSkypeViberEmail
MiscellaneousNational Plan, Policy & GuidelinesNoticeResearch & Publication

Guidance for Annual Review Workshop- MoHP

by Public Health Update
written by Public Health Update

Guidance for Annual Review Workshop- MoHP

DOWNLOAD PDF FILE

Local Level

DOWNLOAD PDF FILE

PROVINCE LEVEL

DOWNLOAD PDF FILE

PRIMARY HEALTH OFFICE LEVEL

DOWNLOAD PDF FILE

Hospital level

DOWNLOAD PDF FILE

Health Sector Progress Report 2018, Ministry of Health & Population

Major achievements of Ministry of Health and Population in the FY 2075-76

National Health Policy 2076- MoHP

Department of Health Services (DoHS) Annual Report 2074/75 (2017/18)

0 comments
0 FacebookTwitterPinterestLinkedinTumblrVKOdnoklassnikiRedditStumbleuponWhatsappTelegramLINEPocketSkypeViberEmail
National Health NewsPublic HealthPublic Health NewsPublic Health Update

Health Ministers of WHO South-East Asia Region to discuss key challenges next week

by Public Health Update
written by Public Health Update

Health Ministers of WHO South-East Asia Region to discuss key challenges next week

New Delhi, 30 August 2019: Health Ministers of member countries of WHO South-East Asia Region are meeting here next week to discuss ways of addressing health impact of climate change, the high burden of tuberculosis and strengthening capacities for emergency risk management.

Elimination of measles, a childhood killer disease; cervical cancer and other non-communicable diseases; and strengthening health services and workforce for universal health coverage are other key issues that will be taken up at the Seventy-Second Regional Committee Session of WHO South-East Asia from 2 September to 6 September 2019.

India’s Minister for Health and Family Welfare Dr Harsh Vardhan, Nepal’s Deputy Prime Minister and Health Minister, Mr Upendra Yadav, and Regional Director, WHO South-East Asia, Dr Poonam Khetrapal Singh, will be addressing the inaugural session of the Regional Committee, the governing body of WHO in the Region. Health ministers and senior officials from all 11 Member countries and senior WHO officials will be attending the week-long deliberations.

This is the first Regional Committee Session after unanimous re-election of Dr Khetrapal Singh as Regional Director for a second five-year term.

Dr Khetrapal Singh, whose first term was marked by unprecedented public health achievements and progress in the Region, would be further firming up regional goals and targets along with Member countries for the next five years.

The Regional Director’s vision for the next five years is to sustain progress, accelerate efforts and innovate to achieve the targets of priority health programmes.

The Region has eight flagship priority programmes – measles elimination and rubella control; preventing non-communicable diseases; reducing maternal, under-five and neonatal mortality; universal health coverage with a focus on human resources for health and essential medicines; combating antimicrobial resistance; scaling up capacities for emergency risk management; eliminating neglected tropical diseases and accelerating efforts to end TB.

The regional priorities are aligned to the UN Sustainable Development Goals and WHO’s global triple billion – one billion more people benefitting from universal health coverage (UHC); one billion more people better protected from health emergencies; and one billion more people enjoying better health and well-being.

Home to over one-fourth of the global population, WHO South-East Asia Region has made remarkable progress in several priority programmes in the last five years. In 2014 the Region was certified polio-free. In 2015 Maldives and was certified malaria-free. Sri Lanka soon achieved the same. In 2016 the Region became the second WHO region to eliminate maternal and neonatal tetanus. In the same year Thailand became the first country in Asia – and the first globally with a large HIV epidemic – to eliminate mother-to-child transmission of HIV and syphilis. Maldives achieved the same in 2019.

Bhutan, Maldives, DPR Korea, Timor-Leste and Sri Lanka have eliminated measles. Bangladesh, Bhutan, Maldives, Nepal, Sri Lanka and Timor-Leste have controlled rubella. Maldives, Sri Lanka and Thailand have eliminated lymphatic filariasis. India is yaws-free; Nepal has eliminated trachoma. Bangladesh, Bhutan, Nepal and Thailand have controlled Hepatitis B.

Between 1990 and 2015 maternal mortality ratio declined by 69%, under-five mortality by 70%. DPR Korea, Indonesia, Maldives, Sri Lanka and Thailand have already achieved global Sustainable Development Goal (SDG) targets for neonatal and under-5 mortality. Maldives, Sri Lanka and Thailand have done the same for maternal mortality.

All countries in the Region have multi-sectoral plans to address non-communicable diseases and are addressing antimicrobial resistance with ‘One Health’ approach.

In the Region’s pursuit of universal health coverage, access to safe, good-quality medicine is being enhanced through the South-East Asia Regulatory Network, which was launched in November 2016. Investments in strengthening capacities for emergency risk management have resulted in better management of major health emergencies such as Nepal earthquake, the recurring events of cyclone, floods etc.

WHO NEPAL 
UN House, Pulchowk | P.O Box: 108 | Lalitpur | Kathmandu | Nepal 
Tel.   +977-1-5523200 
Website: http://www.searo.who.int/nepal

 

Bangladesh, Bhutan, Nepal and Thailand achieve Hepatitis B control: WHO

Bhutan, Maldives eliminate measles

Thailand becomes trans fat free country ??

Algeria and Argentina certified malaria-free by WHO

Nepal: first country in South-East Asia validated for eliminating trachoma

Maldives ?? eliminates mother-to-child transmission of HIV, Syphilis

Sri Lanka ?? eliminates measles

0 comments
0 FacebookTwitterPinterestLinkedinTumblrVKOdnoklassnikiRedditStumbleuponWhatsappTelegramLINEPocketSkypeViberEmail
Newer Posts
Older Posts
Public Health Initiative, A Registered Non-profit organization – All Right Reserved. 2011-2023